The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT06036836
Brief Title: Study of Favezelimab Coformulated With Pembrolizumab (MK-4280A) in Participants With Selected Solid Tumors (MK-4280A-010)
First Submitted : August 21, 2023
First Submitted that Met QC Criteria : September 7, 2023
First Posted : September 14, 2023
Last Update Submitted that Met QC Criteria : May 3, 2024
Last Update Posted : May 6, 2024